Cargando…
Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043)
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589689/ https://www.ncbi.nlm.nih.gov/pubmed/34805646 http://dx.doi.org/10.1016/j.ekir.2021.08.026 |
| _version_ | 1784598783755026432 |
|---|---|
| author | Brilland, Benoit Wacrenier, Samuel Henry, Nicolas Guibert, Fanny Piccoli, Giorgina Barbara Augusto, Jean-François |
| author_facet | Brilland, Benoit Wacrenier, Samuel Henry, Nicolas Guibert, Fanny Piccoli, Giorgina Barbara Augusto, Jean-François |
| author_sort | Brilland, Benoit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8589689 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85896892021-11-19 Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043) Brilland, Benoit Wacrenier, Samuel Henry, Nicolas Guibert, Fanny Piccoli, Giorgina Barbara Augusto, Jean-François Kidney Int Rep Letter to the Editor Elsevier 2021-09-07 /pmc/articles/PMC8589689/ /pubmed/34805646 http://dx.doi.org/10.1016/j.ekir.2021.08.026 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Brilland, Benoit Wacrenier, Samuel Henry, Nicolas Guibert, Fanny Piccoli, Giorgina Barbara Augusto, Jean-François Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043) |
| title | Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043) |
| title_full | Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043) |
| title_fullStr | Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043) |
| title_full_unstemmed | Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043) |
| title_short | Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043) |
| title_sort | low complement c3 levels at diagnosis of anca-associated glomerulonephritis, a specific subset of patients to target with anti-c5ar therapy?: in response to: hypocomplementemia at diagnosis of pauci-immune glomerulonephritis is associated with advanced histopathological activity index and high probability of treatment resistance (lionaki et al., kidney international reports, june 2021, doi: 10.1016/j.ekir.2021.05.043) |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589689/ https://www.ncbi.nlm.nih.gov/pubmed/34805646 http://dx.doi.org/10.1016/j.ekir.2021.08.026 |
| work_keys_str_mv | AT brillandbenoit lowcomplementc3levelsatdiagnosisofancaassociatedglomerulonephritisaspecificsubsetofpatientstotargetwithantic5artherapyinresponsetohypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprob AT wacreniersamuel lowcomplementc3levelsatdiagnosisofancaassociatedglomerulonephritisaspecificsubsetofpatientstotargetwithantic5artherapyinresponsetohypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprob AT henrynicolas lowcomplementc3levelsatdiagnosisofancaassociatedglomerulonephritisaspecificsubsetofpatientstotargetwithantic5artherapyinresponsetohypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprob AT guibertfanny lowcomplementc3levelsatdiagnosisofancaassociatedglomerulonephritisaspecificsubsetofpatientstotargetwithantic5artherapyinresponsetohypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprob AT piccoligiorginabarbara lowcomplementc3levelsatdiagnosisofancaassociatedglomerulonephritisaspecificsubsetofpatientstotargetwithantic5artherapyinresponsetohypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprob AT augustojeanfrancois lowcomplementc3levelsatdiagnosisofancaassociatedglomerulonephritisaspecificsubsetofpatientstotargetwithantic5artherapyinresponsetohypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprob |